PIUG 2016 Biotechnology Conference Presentations – February 2016

PIUG Biotechnology Conference presentation files are provided to PIUG members with permission of the presenters. Further distribution is limited to current PIUG members. PIUG is an organization of individuals and not companies, so sharing presentation files with colleagues who are not PIUG members is against PIUG policy. We welcome new members and renewals per the PIUG Membership Benefits page.

Abstracts, author biographies, and the full program are available on the Final Program page.

Download the full PIUG 2016 Biotech Conference Book just as printed and distributed at the conference.

Reviews of the PIUG 2016 Biotechnology Conference have been written for PIUG members by Gin Eggerichs (link) and Julia Heinrichs ( link). Enjoy these (photos) from the conference.

Welcome Remarks, Greg Roland, PIUG Program Co-Chair along with Alison Taylor

Validity of Antibody Patents in View of Recent Changes to US Case Law, Forrester Liddle, J.D. Novartis

CDR Identification and Searching, Seth Mendelson, Eisai

CRISPR/Cas9 Gene Editing Tool: The Future of the Biotechnology, Deepti Tayal, Ingenious ebrain Solutions

Developments in the Microbiome Space: Tracking Innovation Trends, Larry Mulcahy, Thomson Reuters

CAR Shopping: Finding the Right Chimeric Antigen Receptors for You, Barbara Miller, Novartis Institutes for Biomedical Research

It’s All About Your Colleagues: How Patent Searchers Can Support Each Other to Raise Their Level of Expertise, Doris Roth, Danish Patent and Trademark Office

Computer-assisted Solutions to Understand the Competitive Landscape and Own Patent Creation: Introducing the Chemaxon Biomolecule Toolkit, Arpad Figyelmesi, Chemaxon

Applying Text Mining Technologies to Patent Analyses, Matthew Crawford, Pfizer

Mining Information from Tables within Patents, David Milward, Linguamatics

PIUG-sponsored Workshop: "Navigating NCBI Molecular Data Using the Integrated Entrez System and a Practical Guide to NCBI BLAST" and

Live demos, Peter Cooper, PhD, National Center for Biotechnology Information